The New Avanue For The Human Immunoglobulin (Ph4) For Intravenous Injection Market
The Human Immunoglobulin (pH4) for Intravenous Injection Market is estimated to be valued at US$ 61.6 Bn in 2023 and is expected to exhibit a CAGR of 12. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.